HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4Ei-10

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ahmad, Zeeshan: 2 articles (01/2021 - 01/2020)
2.	Chen, Sierra: 2 articles (01/2021 - 01/2020)
3.	Dillenburg, Maxwell: 2 articles (01/2021 - 01/2020)
4.	Jacobson, Blake A: 2 articles (01/2021 - 01/2020)
5.	Kratzke, Robert A: 2 articles (01/2021 - 01/2020)
6.	Patel, Manish R: 2 articles (01/2021 - 01/2020)
7.	Wagner, Carston R: 2 articles (01/2021 - 01/2020)
8.	Cambron, Daniel A: 1 article (01/2021)
9.	Patel, Anil J: 1 article (01/2021)
10.	Stoian, Emilia: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2020 - "Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma." 01/01/2020 - "Treatment of MM with 4Ei-10 resulted in decreased cell proliferation, increased sensitivity to pemetrexed and altered expression of malignancy-related proteins. "
2.	Mesothelioma 01/01/2020 - "Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma."
3.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/01/2021 - "Using this powerful interaction, it has been demonstrated that 4Ei-10 inhibits non-small cell lung cancer (NSCLC) cell growth. " 01/01/2021 - "4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer."
4.	Malignant Mesothelioma 01/01/2020 - "The effects of inhibiting translation initiation by disruption of the eIF4F complex with 4Ei-10 were examined in malignant mesothelioma (MM). "

Related Drugs and Biologics

1.	Eukaryotic Initiation Factor-4F (EIF4F)
2.	Proteins (Proteins, Gene)
3.	Pemetrexed (MTA)

Related Therapies and Procedures

1.	Therapeutics